Last update 01 Nov 2024

Nanjing Huanglong Biotechnology Co. Ltd.

Subsidiary Company|
2012|
Jiangsu Sheng, China

Overview

Related

2
Clinical Trials associated with Nanjing Huanglong Biotechnology Co. Ltd.
CTR20242639 / Not yet recruitingNot Applicable
南京黄龙生物科技有限公司研制的替米沙坦氢氯噻嗪片（80mg/12.5mg）与Boehringer Ingelheim International GmbH上市的替米沙坦氢氯噻嗪片（美嘉素®，80mg/12.5mg）在中国健康受试者中进行的随机、开放、单剂量、2序列、4周期、交叉、空腹及餐后状态下的生物等效性研究
[Translation] A randomized, open-label, single-dose, 2-sequence, 4-period, crossover, fasting and fed bioequivalence study of telmisartan hydrochlorothiazide tablets (80 mg/12.5 mg) developed by Nanjing Huanglong Biotechnology Co., Ltd. and telmisartan hydrochlorothiazide tablets (Mekasu®, 80 mg/12.5 mg) marketed by Boehringer Ingelheim International GmbH in healthy Chinese subjects
CTR20241442 / CompletedNot Applicable
南京黄龙生物科技有限公司研制的利奥西呱片（2.5 mg）与持证商为Bayer AG的利奥西呱片（商品名：Adempas®/安吉奥®；规格：2.5 mg；参比制剂）在中国健康男性受试者中进行的单中心、随机、开放、两制剂、空腹与餐后、单次给药、两周期、双交叉设计的生物等效性研究
[Translation] A single-center, randomized, open-label, two-dose, fasting and postprandial, single-dose, two-period, double-crossover bioequivalence study of riociguat tablets (2.5 mg) developed by Nanjing Huanglong Biotechnology Co., Ltd. and riociguat tablets (trade name: Adempas®/Angio®; specification: 2.5 mg; reference preparation) from Bayer AG in healthy Chinese male subjects
100 Clinical Results associated with Nanjing Huanglong Biotechnology Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Nanjing Huanglong Biotechnology Co. Ltd.
Login to view more data
100 Deals associated with Nanjing Huanglong Biotechnology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Nanjing Huanglong Biotechnology Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

No data posted
Login to keep update

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free